CompoAtlas

PEA LP

Food supplement declared in France

PEA LP is a food supplement declared in France. Status: retiré du marché le 25 September 2025. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
UNIFARCO SPA
Status
Retiré du marché le 25 September 2025
Form
Comprimé
Daily dose
prendre 1 à 3 comprimés par jour, à avaler avec un peu d‘eau, de préférence au cours des repas

Declaration 338962, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Substances

NamePer day
Palmitoyléthanolamide400 mg

Other active ingredients

NamePer day
Triglycérides à chaine moyennenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011

Additives

E468, E470b, E551, E170, E553b, E1521, E1203, E527, E401, E570, E462, E463, E341, E460

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Enter to analyse, Shift+Enter for a new line